AIM ImmunoTech, Inc. (AIM)

0.7725 -0.07 (-8.44%) USD  |  NYAM  |  Feb 12, 15:26
More

AIM ImmunoTech Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
LadRx Corp. Upgrade
Plus Therapeutics, Inc. Upgrade